CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Azelastine nasal spraydrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00117832
NCT00117832N/ACompleted
CompareCT.gov

Nasal Ocular Reflexes Contribute to Eye Symptoms in Patients With Allergic Rhinitis

University of Chicago·interventional·Posted Jul 8, 2005·Updated Sep 5, 2013

In Brief

A clinical study evaluating Azelastine nasal spray for Rhinitis, Allergic, Seasonal. Completed, across 1 site.

Detailed Summary

Eye symptoms of tearing, redness and itching frequently occur in patients with allergic rhinitis or hayfever. The purpose of this trial is to study whether placing an allergen (a substance that causes allergies) directly in your nose can cause you to have eye symptoms as well as nasal symptoms.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRhinitis, Allergic, Seasonal
CountriesUnited States
CollaboratorsGlaxoSmithKline

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 8, 2005
Enrollment StartMar 1, 2005
Primary CompletionMay 1, 2006
Study CompletionOct 1, 2006
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 21.0 years ago

Interventions

Azelastine nasal spraydrug